Results 11 to 20 of about 3,241 (183)
Introduction Acute myeloid leukemia (AML) with plasmacytoid dendritic cell differentiation (pDC‐AML) is a newly described subtype of leukemia with features resembling blastic plasmacytoid dendritic cell neoplasm (BPDCN).
Benjamin J. Lee +5 more
doaj +2 more sources
Blastic plasmacytoid dendritic cell neoplasm of skin, a rare dermatohematologic malignancy—A case report [PDF]
Key Clinical Message Blastic plasmacytoid dendritic cell neoplasm is a rare hematologic malignancy and appropriate diagnosis encounters difficulties in both clinical and pathologic aspects.
Ramtin Edjtemaei +2 more
doaj +2 more sources
Blastic plasmacytoid dendritic cell neoplasm [PDF]
ABSTRACTBlastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare haematological malignancy that originates from the precursors of plasmacytoid dendritic cells. It commonly presents with findings isolated to the skin although it usually progresses to a leukaemic phase.
Javier, Munoz +4 more
+9 more sources
Blastic plasmacytoid dendritic cell neoplasm
Key Clinical MessageBlastic plasmacytoid dendritic cell neoplasm is an aggressive neoplasm with a median survival of only a few months despite treatment. An exhaustive immunohistochemical workup is required to differentiate it from myeloid sarcoma and extranodal NK/T cell lymphoma.
Manoj Ponadka Rai +4 more
+8 more sources
Hematopoietic effects of tagraxofusp in treatment-naive patients with blastic plasmacytoid dendritic cell neoplasm. [PDF]
Abstract Background Blastic plasmacytoid dendritic cell neoplasm (BPDCN), an aggressive hematologic neoplasm that expresses CD123, is often observed in the bone marrow (BM), as well as skin, blood, and viscera. Tagraxofusp, a first‐in‐class CD123‐targeted therapy, is the only drug approved to treat BPDCN.
Konopleva M +10 more
europepmc +2 more sources
Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report [PDF]
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive neoplastic process of precursor plasmacytoid dendritic cells. The diagnostic evaluation of this heterogenous entity is challenging, requiring a comprehensive approach of ...
Jasper X Zheng +4 more
doaj +2 more sources
Blastic plasmacytoid dendritic cell neoplasm is a rare aggressive myeloid malignancy thought to be derived from precursor plasmacytoid dendritic cells. Rapid progression and poor prognosis have been known.
Kyohei Yoshioka +8 more
doaj +1 more source
Blastic plasmacytoid dendritic cell neoplasm [PDF]
![Figure][1] An 81-year-old man had multiple skin lesions (brown-red plaques on the face, abdomen, and back) and asthenia. There was no hepatosplenomegaly or adenopathy. Despite normal blood count values, the peripheral smear contained blasts (7%).
Fanny, Angelot-Delettre +1 more
+6 more sources
Background Blastic plasmacytoid dendritic cell neoplasm represents a rare type of hematologic malignancy that often manifests itself through various skin lesions. It commonly affects the elderly male population.
Fateme Salemi +5 more
doaj +1 more source
The paper reveals the 5 cases date about blastic plasmacytoid dendritic cell neoplasm. The presented information demonstrates morphological, immunohistochemical data and clinical manifestations.
Andrei A. Sherstnev +3 more
doaj +1 more source

